---
title: "Dexfenfluramine - Obesity"
sidebar: mydoc_sidebar
permalink: db01191-mesh-d009765-1.html
toc: false 
---


Path ID: `DB01191_MESH_D009765_1`
{% include image.html url="images/db01191-mesh-d009765-1.png" file="db01191-mesh-d009765-1.png" alt="db01191-mesh-d009765-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D020372 | dexfenfluramine | Drug |
| UniProt:P31645 | Sodium-dependent serotonin transporter | Protein |
| GO:0051610 | serotonin uptake | BiologicalProcess |
| HP:0100738 | Abnormal eating behavior | PhenotypicFeature |
| MESH:D009765 | Obesity | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Dexfenfluramine | NEGATIVELY REGULATES | Sodium-Dependent Serotonin Transporter |
| Sodium-Dependent Serotonin Transporter | POSITIVELY REGULATES | Serotonin Uptake |
| Serotonin Uptake | AFFECTS RISK FOR | Abnormal Eating Behavior |
| Abnormal Eating Behavior | POSITIVELY CORRELATED WITH | Obesity |
|---------|-----------|---------|

Comment: FDA has withdrawn the approval for marketing this drug as per its cardiovascular side-effects.

Reference: 
  - [https://go.drugbank.com/drugs/DB01191#mechanism-of-action](https://go.drugbank.com/drugs/DB01191#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Dexfenfluramine](https://en.wikipedia.org/wiki/Dexfenfluramine)
